Zoetis Partners With Nestlé To Set Up Dairy Farming Institute In China

Zoetis Partners With Nestlé To Set Up Dairy Farming Institute In China

SHANGHAI, CHINA – Oct. 15, 2014 Zoetis Inc. and Nestlé today announced an agreement in which Zoetis will develop the educational curriculum for the Dairy Farming Institute (DFI) in Shuangcheng, Heilongjiang Province in Northeast China.

Zoetis will bring to the Institute and its partner organizations veterinary medical and technical expertise. The company will leverage its veterinary and dairy producer relationships to advance the work of the Institute in helping China's dairy farmers meet the country's need for safe, high quality milk and dairy foods in a sustainable manner.

As a key partner, Zoetis will establish a technical and training team to support the dairy farming education. This includes development of relevant training curriculum and materials in the area of animal health.  

China is one of the fastest growing markets for milk products globally and the market could almost double in volume by 2020 from current levels.  Through the Institute, Zoetis and Nestlé aim to drive greater awareness about sustainable health and welfare of cattle and improving productivity while providing safe and nutritious milk.

Speaking about the partnership, Qing Wang, General Manager, China at Zoetis said, "Zoetis combines the local presence and knowledge with the global reach and resources essential to help advance animal health in China. We will work with Nestlé to engage stakeholders with the objective to modernize the dairy industry in China through knowledge sharing and technical training."

In addition to the delivery of science based, innovative products to support the dairy industry, Zoetis has ongoing partnerships to advance veterinary medical education and animal health in mainland China through the Chinese Veterinary Medical Association (CVMA) and International Veterinary Collaboration for China (IVCC), a consortium of leading veterinary medical schools in the United States and United Kingdom. The focus of the IVCC is in three areas: enhancing dairy and swine health and productivity through improved management; veterinary education; and increasing veterinary public health awareness and education. 

John Cheung, Nestlé China Chairman and Chief Executive said, "Nestlé and its alliance partners will share their technical know-how to improve dairy farming in China. Efforts will include training, responsible practices and partnering with stakeholders, including governments and universities. Zoetis brings with it the distinct advantage of its technical expertise and training experience that will add tremendous value to the Institute." 

The University of Wisconsin Madison and Northeast Agricultural University in Heilongjiang Province are the academic partners of DFI.

The Institute will include classrooms, laboratories, dormitories, and three different sized training farms to facilitate the training courses. The Institute expects to train around 700 students annually through 17 different course offerings. Zoetis will apply its expertise across many of these facilities, with a special focus on protecting the health and well-being of young animals from birth until they enter the herd.

About Zoetis

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 27 manufacturing facilities in 10 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries.  For more information, visit www.zoetis.com.

Media Contacts:

Priya Chandramohan
+86 21 22610265
[email protected]    

Yu Fang
+86 21 22610265
[email protected]

 

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…